Why Choose Auburn Pharmaceutical?

  • No Contracts!
  • Hassle Free Return Policy
  • Great Savings on Short Date Items
  • Great Value on Close-out Items
  • Free Shipping (orders of $75 or more)
  • Over 3,000 AB Rated Generics
  • Fully Accredited
  • VAWD Accredited

Auburn Pharmaceutical has become one of the fastest growing generic distributors in the country. We proudly serve over 2,500 independent pharmacies, chains, hospitals and governmental agencies.

Auburn Pharmaceutical is a family-owned and operated business, established in 1993. The family has been involved in the generic pharmaceutical industry for over 45 years.

See why Auburn Pharmaceutical is "DIFFERENT" from the rest. Register and get started today!

"I have had superb experience with Auburn, especially with our rep, due to the company's general values, deals and personal ability"
Ryan from Wisconsin

"Auburn is very competitive with pricing as well as great customer service. The sales rep I have is personable and courteous"
Jay from Kentucky

"It has been a very positive, professional and enjoyable experience dealing with the company and particularly our rep, she's a delight"
Camille from Ohio

"Ordering through Auburn has always been an easy experience. The staff is friendly with no pressure to buy, but knowledgeable on specials and upcoming shortages."
Lorraine from Michigan

Rite Aid enters fifth Health Alliance partnership

Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.

read more

Tuesday July 08, 2014

Latest evolution of RAD Wellness ‘90210-worthy’ - Part 1

Rite Aid celebrated the latest evolution of its Wellness store format, with a June 23 grand opening truly befitting of its 90210 address.

read more

Tuesday July 08, 2014

Reckitt Benckiser to spin off pharma business over next 12 months

Reckitt Benckiser on Monday announced the company will be looking to spin off its pharma business in the next 12 months. 

read more

Monday July 28, 2014

Imbruvica gets expanded approval from FDA

The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.

read more

Monday July 28, 2014